Connor, Clark & Lunn Investment Management Ltd. Axogen, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Axogen, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 288,745 shares of AXGN stock, worth $5.78 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
288,745
Previous 308,686
6.46%
Holding current value
$5.78 Million
Previous $4.33 Million
9.96%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding AXGN
# of Institutions
179Shares Held
36.2MCall Options Held
82.6KPut Options Held
1.1K-
First Light Asset Management, LLC Edina, MN4.51MShares$90.2 Million7.26% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$65 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.96MShares$59.1 Million3.39% of portfolio
-
Morgan Stanley New York, NY2.43MShares$48.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$48.5 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $846M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...